BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 45 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,606,000 | -38.5% | 2,606,000 | -19.1% | 0.10% | -40.8% |
| Q2 2020 | $4,239,000 | +17.4% | 3,221,000 | -5.5% | 0.17% | -7.9% |
| Q1 2020 | $3,612,000 | -42.5% | 3,407,000 | -41.0% | 0.19% | -23.8% |
| Q4 2019 | $6,280,000 | +5.1% | 5,777,000 | 0.0% | 0.25% | +3.8% |
| Q3 2019 | $5,977,000 | -8.1% | 5,777,000 | 0.0% | 0.24% | -2.4% |
| Q2 2019 | $6,503,000 | -4.4% | 5,777,000 | -3.7% | 0.24% | +4.3% |
| Q1 2019 | $6,799,000 | -14.8% | 5,997,000 | -16.4% | 0.24% | -16.1% |
| Q4 2018 | $7,979,000 | -5.5% | 7,175,000 | +1.8% | 0.28% | +16.7% |
| Q3 2018 | $8,441,000 | – | 7,045,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,000,000 | $5,003,000 | 2.71% |
| Weiss Asset Management LP | 65,841,000 | $64,360,000 | 2.62% |
| Davide Leone & Partners Investment Co Ltd. | 10,500,000 | $10,513,000 | 1.19% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,597,000 | $29,800,000 | 1.14% |
| GLAZER CAPITAL, LLC | 7,483,000 | $7,474,000 | 0.36% |
| BLUEFIN CAPITAL MANAGEMENT, LLC | 52,500 | $5,243,000 | 0.33% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,428,000 | $13,444,000 | 0.29% |
| CSS LLC/IL | 5,500,000 | $5,498,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 40,182,000 | $40,159,000 | 0.23% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,606,000 | $2,606,000 | 0.10% |